Though numerous studies have been undertaken showing the efficacy of drug therapies for breast cancer prevention, many primary and secondary care professionals remain unaware that these preventative treatments exist. In fact, drugs such as Tamoxifen are both extremely safe and provide protection long after the suggested five-year course of treatment. Produced in collaboration with Health Innovation Manchester and featuring a panel consisting of breast surgeon Ms Rosie Stanton; Macmillan GP Clinical Cancer Lead Dr Nicola Weaver; Dr Sacha Howel, medical oncologist and Senior Lecturer at the University of Manchester; and Dr Gareth Evans, professor of medical genetics and cancer epidemiology at the University of Manchester, this podcast aims to give surgeons and other health care professionals an overview of the treatments available, how they work and which groups of patients would most benefit from them. To send us feedback or propose a topic for a future podcast, please get in touch at [email protected] Visit Health Innovation Manchester for more information on their suite of breast cancer prevention learning resources.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related